Literature DB >> 32437308

Basic Mechanisms of Diabetic Heart Disease.

Rebecca H Ritchie1, E Dale Abel2,3.   

Abstract

Diabetes mellitus predisposes affected individuals to a significant spectrum of cardiovascular complications, one of the most debilitating in terms of prognosis is heart failure. Indeed, the increasing global prevalence of diabetes mellitus and an aging population has given rise to an epidemic of diabetes mellitus-induced heart failure. Despite the significant research attention this phenomenon, termed diabetic cardiomyopathy, has received over several decades, understanding of the full spectrum of potential contributing mechanisms, and their relative contribution to this heart failure phenotype in the specific context of diabetes mellitus, has not yet been fully resolved. Key recent preclinical discoveries that comprise the current state-of-the-art understanding of the basic mechanisms of the complex phenotype, that is, the diabetic heart, form the basis of this review. Abnormalities in each of cardiac metabolism, physiological and pathophysiological signaling, and the mitochondrial compartment, in addition to oxidative stress, inflammation, myocardial cell death pathways, and neurohumoral mechanisms, are addressed. Further, the interactions between each of these contributing mechanisms and how they align to the functional, morphological, and structural impairments that characterize the diabetic heart are considered in light of the clinical context: from the disease burden, its current management in the clinic, and where the knowledge gaps remain. The need for continued interrogation of these mechanisms (both known and those yet to be identified) is essential to not only decipher the how and why of diabetes mellitus-induced heart failure but also to facilitate improved inroads into the clinical management of this pervasive clinical challenge.

Entities:  

Keywords:  diabetes mellitus; diabetic cardiomyopathy; fibrosis; heart diseases; heart failure; oxidative stress; ventricular remodelling

Mesh:

Year:  2020        PMID: 32437308      PMCID: PMC7251974          DOI: 10.1161/CIRCRESAHA.120.315913

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  371 in total

1.  Prevalence and prognostic implications of pre-diabetic state in patients with heart failure.

Authors:  Yuya Matsue; Makoto Suzuki; Rena Nakamura; Masami Abe; Maki Ono; Seigo Yoshida; Mie Seya; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Akihiko Matsumura; Yuji Hashimoto
Journal:  Circ J       Date:  2011-10-19       Impact factor: 2.993

2.  Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.

Authors:  Xuehong Diao; E Shen; Xiaoxia Wang; Bing Hu
Journal:  Mol Med Rep       Date:  2011-05-16       Impact factor: 2.952

Review 3.  Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.

Authors:  Adam J Wilson; Eleanor K Gill; Rawan A Abudalo; Kevin S Edgar; Chris J Watson; David J Grieve
Journal:  Heart       Date:  2017-09-27       Impact factor: 5.994

4.  Cardiac sarcoplasmic reticulum function in insulin- or carnitine-treated diabetic rats.

Authors:  G D Lopaschuk; A G Tahiliani; R V Vadlamudi; S Katz; J H McNeill
Journal:  Am J Physiol       Date:  1983-12

5.  Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy?

Authors:  S M Factor; T Minase; S Cho; F Fein; J M Capasso; E H Sonnenblick
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

6.  Myocardial dysfunction identified by three-dimensional speckle tracking echocardiography in type 2 diabetes patients relates to complications of microangiopathy.

Authors:  Mami Enomoto; Tomoko Ishizu; Yoshihiro Seo; Yuri Kameda; Hiroaki Suzuki; Hiroshi Shimano; Yasushi Kawakami; Kazutaka Aonuma
Journal:  J Cardiol       Date:  2016-04-14       Impact factor: 3.159

7.  Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study.

Authors:  Magnus T Jensen; Peter Sogaard; Ida Gustafsson; Jan Bech; Thomas F Hansen; Thomas Almdal; Simone Theilade; Tor Biering-Sørensen; Peter G Jørgensen; Søren Galatius; Henrik U Andersen; Peter Rossing
Journal:  Diabetologia       Date:  2019-10-30       Impact factor: 10.122

8.  Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes.

Authors: 
Journal:  Diabetes Care       Date:  2016-01-28       Impact factor: 19.112

9.  Differential hexosamine biosynthetic pathway gene expression with type 2 diabetes.

Authors:  Megan Coomer; M Faadiel Essop
Journal:  Mol Genet Metab Rep       Date:  2014-04-17

10.  Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia.

Authors:  Chanchal Chandramouli; Melissa E Reichelt; Claire L Curl; Upasna Varma; Laura A Bienvenu; Parisa Koutsifeli; Antonia J A Raaijmakers; Miles J De Blasio; Cheng Xue Qin; Alicia J Jenkins; Rebecca H Ritchie; Kimberley M Mellor; Lea M D Delbridge
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

View more
  60 in total

Review 1.  Left atrial function in diabetes: does it help?

Authors:  Marijana Tadic; Cesare Cuspidi
Journal:  Acta Diabetol       Date:  2020-06-09       Impact factor: 4.280

Review 2.  Krüppel-like factor (KLF)5: An emerging foe of cardiovascular health.

Authors:  Dimitra Palioura; Antigone Lazou; Konstantinos Drosatos
Journal:  J Mol Cell Cardiol       Date:  2021-10-13       Impact factor: 5.000

3.  Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

Authors:  Barbara K Kemp-Harper; Anida Velagic; Nazareno Paolocci; John D Horowitz; Rebecca H Ritchie
Journal:  Handb Exp Pharmacol       Date:  2021

Review 4.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

5.  KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.

Authors:  Ioannis D Kyriazis; Matthew Hoffman; Lea Gaignebet; Anna Maria Lucchese; Eftychia Markopoulou; Dimitra Palioura; Chao Wang; Thomas D Bannister; Melpo Christofidou-Solomidou; Shin-Ichi Oka; Junichi Sadoshima; Walter J Koch; Ira J Goldberg; Vincent W Yang; Agnieszka B Bialkowska; Georgios Kararigas; Konstantinos Drosatos
Journal:  Circ Res       Date:  2020-12-02       Impact factor: 17.367

6.  Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition.

Authors:  Alexander R Pinto; Rebecca H Ritchie; Charles D Cohen; Miles J De Blasio; Man K S Lee; Gabriella E Farrugia; Darnel Prakoso; Crisdion Krstevski; Minh Deo; Daniel G Donner; Helen Kiriazis; Michelle C Flynn; Taylah L Gaynor; Andrew J Murphy; Grant R Drummond
Journal:  Cardiovasc Diabetol       Date:  2021-06-01       Impact factor: 9.951

Review 7.  Fructose Metabolism and Cardiac Metabolic Stress.

Authors:  M Annandale; L J Daniels; X Li; J P H Neale; A H L Chau; H A Ambalawanar; S L James; P Koutsifeli; L M D Delbridge; K M Mellor
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

Review 8.  The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury.

Authors:  Li Ning; Xiong Rui; Wang Bo; Geng Qing
Journal:  Cell Death Dis       Date:  2021-07-23       Impact factor: 8.469

Review 9.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

10.  NAD+ Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy.

Authors:  Ying Ann Chiao; Akash Deep Chakraborty; Christine M Light; Rong Tian; Junichi Sadoshima; Xiaojian Shi; Haiwei Gu; Chi Fung Lee
Journal:  Circ Heart Fail       Date:  2021-08-10       Impact factor: 10.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.